MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination Meeting Abstract


Authors: Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; Duke, W.; Jan, M.; Leventhal, M.; Ho, V.; Hobbs, G.; Knudsen, T. A.; Skov, V.; Kjaer, L.; Larsen, T. S.; Hansen, D. L.; Lindsley, R. C.; Hasselbalch, H.; Grauslund, J.; Andersen, M.; Holmstrom, M.; Chan, T.; Rampal, R.; Abdel-Wahab, O.; Bhardwaj, N.; Wolchok, J.; Mullally, A.; Merghoub, T.
Abstract Title: MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
Meeting Title: 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 8
Issue: Suppl. 3
Meeting Dates: 2020 Nov 9-14
Meeting Location: Virtual
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2020-11-01
Start Page: A270
Language: English
ACCESSION: WOS:000616665300432
DOI: 10.1136/jitc-2020-SITC2020.0444
PROVIDER: wos
Notes: Meeting Abstract: 444 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy Chan
    317 Chan
  2. Jedd D Wolchok
    905 Wolchok
  3. Taha Merghoub
    365 Merghoub
  4. Raajit Kumar Rampal
    350 Rampal
  5. Arnab Ghosh
    65 Ghosh
  6. Stephane Pourpe
    12 Pourpe
  7. Mathieu Gigoux
    23 Gigoux
  8. Sara Schad
    13 Schad
  9. Svena Verma
    13 Verma